Evaluation of a Polyherbal Formulation on the Management of Migraine Headaches due to Functional Dyspepsia: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial

Table 4

Correlation of duration, severity, frequency of MH attacks and HIT-6, at the end of intervention (week 12) with a score of FD at the end of intervention according to Spearman’s Rho test.

Group NO	Duration	Severity	Frequency	HIT-6
Group 1	= 0.28	= 0.02	= −0.4	= 0.29
Group 2	= 0.14	= 0.45	= 0.31	= 0.47
Group 3	= 0.55	= 0.57	= 0.41	= 0.66

Group 1: the polyherbal formulation capsule 1500 mg (two capsules of 750 mg) three times a day, + Depakine® tablet 200 mg twice a day + Amitriptyline tablet 10 mg once a day; Group 2: Depakine® tablet 200 Mg twice a day + Amitriptyline 10 mg once a day + the polyherbal formulation placebo capsule three times a day; Group 3: the polyherbal formulation capsule 1500 mg (two capsules of 750 mg) three times a day + Depakine® placebo tablet twice a day.